These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37276927)

  • 1. Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment.
    Wolfová K; Otevřelová P; Holoubek A; Brodská B
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119501. PubMed ID: 37276927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.
    Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B
    Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
    Brodská B; Holoubek A; Otevřelová P; Kuželová K
    J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
    Li J; Zhang X; Sejas DP; Pang Q
    Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation.
    Ma T; Yamada S; Ichwan SJ; Iseki S; Ohtani K; Otsu M; Ikeda MA
    Biochem Biophys Res Commun; 2012 Jan; 417(3):931-7. PubMed ID: 22166212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
    Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
    Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.
    Surget S; Descamps G; Brosseau C; Normant V; Maïga S; Gomez-Bougie P; Gouy-Colin N; Godon C; Béné MC; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C
    BMC Cancer; 2014 Jun; 14():437. PubMed ID: 24927749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleophosmin sets a threshold for p53 response to UV radiation.
    Maiguel DA; Jones L; Chakravarty D; Yang C; Carrier F
    Mol Cell Biol; 2004 May; 24(9):3703-11. PubMed ID: 15082766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
    Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
    Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway.
    Pfister AS; Keil M; Kühl M
    J Biol Chem; 2015 Apr; 290(17):10905-18. PubMed ID: 25759387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
    Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM
    Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
    Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
    Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.
    Xiao S; Caglar E; Maldonado P; Das D; Nadeem Z; Chi A; Trinité B; Li X; Saxena A
    PLoS One; 2014; 9(10):e109858. PubMed ID: 25313645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
    Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
    N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.
    Nalabothula N; Chakravarty D; Pierce A; Carrier F
    Mol Cell Pharmacol; 2010; 2(5):179-189. PubMed ID: 21499441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
    Chen D; Yoon JB; Gu W
    Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chk2 mediates RITA-induced apoptosis.
    de Lange J; Verlaan-de Vries M; Teunisse AF; Jochemsen AG
    Cell Death Differ; 2012 Jun; 19(6):980-9. PubMed ID: 22158418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.